UBS Group’s Motif Bio plc ADRs MTFB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,994
| Closed | -$1K | – | 8704 |
|
|
2019
Q3 | $1K | Buy |
+2,994
| New | +$1.87K | ﹤0.01% | 7927 |
|
|
2019
Q1 | – | Sell |
-1,379
| Closed | -$9K | – | 8476 |
|
|
2018
Q4 | $9K | Buy |
1,379
+420
| +44% | +$3.13K | ﹤0.01% | 7316 |
|
|
2018
Q3 | $8K | Sell |
959
-891
| -48% | -$7.59K | ﹤0.01% | 7306 |
|
|
2018
Q2 | $15K | Buy |
1,850
+318
| +21% | +$2.96K | ﹤0.01% | 6912 |
|
|
2018
Q1 | $15K | Buy |
1,532
+1,227
| +402% | +$12.6K | ﹤0.01% | 6638 |
|
|
2017
Q4 | $3K | Buy |
+305
| New | +$3.03K | ﹤0.01% | 7569 |
|
|
2017
Q3 | – | Sell |
-739
| Closed | -$6K | – | 8168 |
|
|
2017
Q2 | $6K | Buy |
+739
| New | +$6.08K | ﹤0.01% | 7074 |
|
|
2017
Q1 | – | Sell |
-2,309
| Closed | -$14K | – | 8189 |
|
|
2016
Q4 | $14K | Buy |
+2,309
| New | +$13.4K | ﹤0.01% | 6743 |
|
UBS Group's MTFB Position: Q4 2019 in Review
UBS Group sold out of Motif Bio plc ADRs (MTFB) in Q4 2019, closing a stake of 2,994 shares — an estimated $1K sold.
UBS Group first reported a position in MTFB in Q4 2016 and held it in 8 quarters. The position peaked at $15K in Q2 2018. 0 funds tracked by Wall St. Rank hold MTFB as of Q4 2019.
- UBS Group reported no remaining Motif Bio plc ADRs position as of Q4 2019 after selling out during the quarter.
- UBS Group sold 2,994 Motif Bio plc ADRs shares in Q4 2019, an estimated $1K.
- UBS Group first reported a position in Motif Bio plc ADRs in Q4 2016 and held it in 8 quarters.
- UBS Group's Motif Bio plc ADRs position peaked at $15K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Motif Bio plc ADRs as of Q4 2019.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.